Findings showed a 13.6% reduction in body weight in the semaglutide 25mg group compared with a 2.2% reduction in the placebo group.

The chart below compares the cost of an annualized semaglutide dosage from Hims, versus competitors: The pivot to liraglutide will allow Hims & Hers to prolong its operations in the weight-loss ...

The shape of the AUC has implications for dosage conversions even if the 2.5:1 ratio applies for most patients. In other words, the total drug exposure as noted by the AUC may be similar for an i ...

Pfizer has decided to discontinue the development of its oral obesity drug danuglipron, despite promising results from dose-optimization ... Novo Nordisk markets its semaglutide drug as Wegovy ...